FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015

Share Article

US authorities are holding imports more than ever before, particularly at ports that have a history of holding products, and imports from India. Attend this invaluable webinar and find out how to be in the “Safe Zone” when it comes to dealings with the FDA and Customs.

Negotiating an FDA Import Hold Crisis:
Strategies for Challenging FDA Findings
**FDAnews Webinar**
Sept. 22, 2015 — 1:30 p.m. – 3:00 p.m. EDT
http://www.fdanews.com/importholdcrisis

US authorities are holding imports more than ever before, particularly at ports that have a history of holding products, and imports from India.

With alerts on an uptick and a new final rule, having a top-notch import compliance program is crucial.

That's why on Tuesday, Sept. 22, 2015, FDAnews and import hold expert Ben England are joining forces to present Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings.

Attend this invaluable webinar and find out how to be in the “Safe Zone” when it comes to dealings with the FDA and Customs. In just 90 minutes, attendees will gain a clear understanding of the FDA’s expectations and qualifications and Customs’ operational processes. Attendees will also learn:

  • The inside scoop from a former FDA import official on the FDA's latest priorities and expectations
  • What to do to minimize the risk of delays, detentions and refusals
  • How to work closely with suppliers, contract manufacturers and labelers to significantly reduce hold times
  • How to conduct a gap analysis to identify weaknesses in existing compliance programs

Don't take the chance of having imports held at Customs for reasons that aren't obvious or clear.

Instead, join FDAnews and expert Ben England on Tuesday, Sept. 22, 2015 for a webinar that will give attendees a full understanding of the FDA’s priorities when they're trying to comply with import holds and regulations.

Meet the Presenter:
Ben England served as the FDA's Regulatory Counsel to the Associate Commissioner for Regulatory Affairs for 17 years.

He is currently CEO of FDAImports.com, an FDA consulting firm helping U.S. and foreign companies navigate through and meet complex FDA regulations for marketing and importing foods, dietary supplements, drugs, cosmetics and medical devices. The firm serves clients in over 120 countries and operates worldwide offices in several countries.

Who Will Benefit:

  •     Regulatory compliance officers
  •     Supply chain managers
  •     Manufacturing directors and supervisors
  •     Executive Management

Conference Details:
Negotiating an FDA Import Hold Crisis:
Strategies for Challenging FDA Findings
**FDAnews Webinar**
Sept. 22, 2015 — 1:30 p.m. – 3:00 p.m. EDT
http://www.fdanews.com/importholdcrisis

Tuition:
$287 per site

Easy Ways to Register:
Online: http://www.fdanews.com/importholdcrisis
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website